Back to top

earnings-expectations: Archive

Zacks Equity Research

Ahead of Cambium (CMBM) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Cambium (CMBM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.

CMBMNegative Net Change

Zacks Equity Research

Agilysys (AGYS) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Agilysys (AGYS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.

AGYSPositive Net Change

Zacks Equity Research

Countdown to AirSculpt Technologies (AIRS) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS

Evaluate the expected performance of AirSculpt Technologies (AIRS) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

AIRSNegative Net Change

Zacks Equity Research

Gear Up for CommScope (COMM) Q1 Earnings: Wall Street Estimates for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for CommScope (COMM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.

COMMPositive Net Change

Zacks Equity Research

Stay Ahead of the Game With Cerence (CRNC) Q2 Earnings: Wall Street's Insights on Key Metrics

Get a deeper insight into the potential performance of Cerence (CRNC) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

CRNCNegative Net Change

Zacks Equity Research

Health Catalyst (HCAT) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Get a deeper insight into the potential performance of Health Catalyst (HCAT) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

HCATNegative Net Change

Zacks Equity Research

Want Better Returns? Don?t Ignore These 2 Retail and Wholesale Stocks Set to Beat Earnings

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

GPSPositive Net Change ANFPositive Net Change

Zacks Equity Research

Why Investors Need to Take Advantage of These 2 Finance Stocks Now

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

BNSPositive Net Change GSPositive Net Change

Zacks Equity Research

How to Boost Your Portfolio with Top Retail and Wholesale Stocks Set to Beat Earnings

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

WSMPositive Net Change DECKPositive Net Change

Zacks Equity Research

These 2 Retail and Wholesale Stocks Could Beat Earnings: Why They Should Be on Your Radar

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

MPositive Net Change TJXPositive Net Change

Zacks Equity Research

Nextracker (NXT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Nextracker (NXT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NXTNegative Net Change ARRYNegative Net Change

Zacks Equity Research

Analysts Estimate W&T Offshore (WTI) to Report a Decline in Earnings: What to Look Out for

W&T (WTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

WTIPositive Net Change

Zacks Equity Research

Earnings Preview: International Game Technology (IGT) Q1 Earnings Expected to Decline

IGT (IGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IGTNegative Net Change PLTKPositive Net Change

Zacks Equity Research

Will Tango Therapeutics, Inc. (TNGX) Report Negative Q1 Earnings? What You Should Know

Tango Therapeutics (TNGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TNGXNegative Net Change INSMNegative Net Change

Zacks Equity Research

TXO Partners LP (TXO) Expected to Beat Earnings Estimates: Should You Buy?

TXO Partners LP (TXO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TXOPositive Net Change

Zacks Equity Research

Novavax (NVAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Novavax (NVAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NVAXPositive Net Change ANIPPositive Net Change

Zacks Equity Research

Eos Energy Enterprises, Inc. (EOSE) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Eos Energy Enterprises (EOSE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EOSENegative Net Change

Zacks Equity Research

Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Xoma (XOMA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

XOMAPositive Net Change GRTSNegative Net Change

Zacks Equity Research

On Holding (ONON) Q1 Earnings Preview: What's in the Cards?

On Holding (ONON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ONONNegative Net Change YETIPositive Net Change

Zacks Equity Research

Analysts Estimate Jack In The Box (JACK) to Report a Decline in Earnings: What to Look Out for

Jack In The Box (JACK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

JACKNegative Net Change MHGUPositive Net Change

Zacks Equity Research

Dine Brands (DIN) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Dine Brands (DIN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.

DINNegative Net Change

Zacks Equity Research

Unveiling Cheesecake Factory (CAKE) Q1 Outlook: Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Cheesecake Factory (CAKE) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

CAKEPositive Net Change

Zacks Equity Research

Exploring Analyst Estimates for AMC Networks (AMCX) Q1 Earnings, Beyond Revenue and EPS

Beyond analysts' top -and-bottom-line estimates for AMC Networks (AMCX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.

AMCXPositive Net Change

Zacks Equity Research

Blend Labs (BLND) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Blend Labs (BLND), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.

BLNDPositive Net Change

Zacks Equity Research

Unveiling Sally Beauty (SBH) Q2 Outlook: Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Sally Beauty (SBH) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

SBHNegative Net Change